Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange 07:30:00 29/09/2026 BST			5-day change	1st Jan Change
2,281.00 ^JPY	-1.30%		-3.06%	-6.17%

06-30	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
06-22	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	400,118	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-12.9%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	400,118	400,118	400,118
Change	-	11%	26.5%	2.46%	24.61%	32.52%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	17.2x	14.5x	15.1x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.8x	0.76x	0.77x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.8x	-3.71x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.13x	0.12x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.13x	0.12x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	7.75x	7.66x	7.62x
EV / EBIT	0x	0x	0x	0x	0x	11.6x	10.8x	10.5x
EV / FCF	0x	-0x	0x	-0x	0x	19.1x	24.5x	33.3x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.25%	4.09%	3%
Dividend per Share ²	54	57	70	63	68	71	79.67	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.11%	3.49%	3.73%
EPS ²	153.6	127.4	154.1	147.5	229.6	132.4	157	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	53.6%	50.8%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,193,819	3,288,778	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	51,628	52,221	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,398	36,942	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,414	27,149	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,281.00	2,281.00	2,281.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	16/05/22	15/05/23	14/05/24	15/05/25	15/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALFRESA HOLDINGS CORPORATION	17.72x	-	-	3.03%	2.61B
ABBOTT LABORATORIES	28.61x	3.96x	15.3x	2.55%	175B
MEDTRONIC PLC	18.93x	3.47x	12.41x	3.15%	114B
CENCORA, INC.	16.64x	0.19x	12.23x	0.78%	57.98B
BECTON, DICKINSON AND COMPANY	35.43x	3.42x	11.72x	2.13%	50.07B
HOYA CORPORATION	28.77x	7.1x	18.35x	1.39%	50.13B
DEXCOM, INC.	34.75x	6.11x	19.18x	-.--%	32.71B
MEDLINE INC.	46x	1.3x	12.07x	0.21%	30.77B
WEST PHARMACEUTICAL SERVICES, INC.	43.81x	7.69x	27.57x	0.24%	26.44B
SARTORIUS STEDIM BIOTECH	55.45x	7.38x	23.73x	0.38%	23.96B
Average	32.61x	4.51x	16.95x	1.39%	56.39B
Weighted average by Cap.	29.14x	4.00x	15.33x	1.87%